Immunotherapy for Mesothelioma: Rationale and New Approaches

  Abstract: Therapeutic advancement for mesothelioma has been stagnant, with minimal treatment innovation in the past decade. Recently, however, immune checkpoint blockade (ICB) targeting the programmed […]